ENHARNEX Trademark
ENHARNEX is a USPTO trademark filed by Celgene Corporation. Status: Registered.
Trademark Facts
| Mark | ENHARNEX |
|---|---|
| Serial Number | 88632332 |
| Registration Number | 6052097 |
| Status | Registered |
| Filing Date | 2019-09-26 |
| Registration Date | 2020-05-12 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Celgene Corporation |
| Attorney of Record | Marilyn F. Kelly |
| Prosecution Events | 22 |
| Latest Event | REM1 on 2025-05-12 |
Goods & Services
Pharmaceutical preparations for use in the treatment of cancer and auto-immune diseases, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use